Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- A3146 AGI-6780Target: IDH2Summary: IDH2/R140Q mutation inhibitor
- A3178 AN-2728Summary: PDE4 inhibitor,anti-inflammatory compound
- A3215 AZD7687Target: DGATSummary: DGAT inhibitor,potent and selective
- A3216 BalaglitazoneSummary: PPAR-γ partial agonist
- A3277 CapadenosonSummary: Adenosine A1 receptor agonist
- A3358 DeltarasinTarget: Phosphodiesterases (PDEs)Summary: KRAS-PDEδ interaction inhibitor
- A3363 DGAT-1 inhibitorSummary: Diacylglycerol acyltransferase (DGAT1) inhibitor
- A3369 DMP 777Summary: Leukocyte elastase (HLE) inhibitor
- A3374 DronedaroneTarget: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4 and 2D6 inhibitor,moderate
- A3404 EtomoxirSummary: (CPT)-1 and DGAT activity inhibitor